![Table 3 from Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia. | Semantic Scholar Table 3 from Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a9e459777276a68e48f8c76f19425bdaae7a6e07/1-Table3-1.png)
Table 3 from Resource Use and Health Care Costs of Chronic Obstructive Pulmonary Disease in Slovakia. | Semantic Scholar
![Amitoj Acharya on X: "@HarjitSajjan @CPHO_Canada ?Inhaled treatment for asthma and copd? Consult doctor for sure, do not rely on following for various reasons. Level1:SABA+Montelukast? L2:SABA+SAMA,? L3: ICS+LABA or LAMA? L4: Intravenous(IV) Amitoj Acharya on X: "@HarjitSajjan @CPHO_Canada ?Inhaled treatment for asthma and copd? Consult doctor for sure, do not rely on following for various reasons. Level1:SABA+Montelukast? L2:SABA+SAMA,? L3: ICS+LABA or LAMA? L4: Intravenous(IV)](https://pbs.twimg.com/media/ESSKIW8U4AA4Yv5.jpg)
Amitoj Acharya on X: "@HarjitSajjan @CPHO_Canada ?Inhaled treatment for asthma and copd? Consult doctor for sure, do not rely on following for various reasons. Level1:SABA+Montelukast? L2:SABA+SAMA,? L3: ICS+LABA or LAMA? L4: Intravenous(IV)
![Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X](https://pbs.twimg.com/media/DtzVlWsWwAArrfB.jpg)
Dr Nick Hopkinson on X: "New @NICEcomms 2018 COPD guideline update. Initial inhaler pathway - offer LAMA/LABA to most, consider LABA/ICS for some https://t.co/20Qy0Zc5DE @BTSrespiratory @lunguk #BTSWinter2018 4/6 https://t.co/uepZ7YPZsV" / X
![Flow chart (blue: primary analysis, green: replication study). Drug of... | Download Scientific Diagram Flow chart (blue: primary analysis, green: replication study). Drug of... | Download Scientific Diagram](https://www.researchgate.net/publication/303504059/figure/fig4/AS:960041590984723@1605903160494/Flow-chart-blue-primary-analysis-green-replication-study-Drug-of-interest-at-least.gif)
Flow chart (blue: primary analysis, green: replication study). Drug of... | Download Scientific Diagram
![Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice. - Abstract - Europe PMC Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice. - Abstract - Europe PMC](https://europepmc.org/articles/PMC4664433/bin/copd-10-2535Fig1.jpg)
Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice. - Abstract - Europe PMC
![Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study - ScienceDirect Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0954611118302397-gr1.jpg)
Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study - ScienceDirect
![GOLD 2011 pharmacologic management of COPD based on combined assessment... | Download Scientific Diagram GOLD 2011 pharmacologic management of COPD based on combined assessment... | Download Scientific Diagram](https://www.researchgate.net/publication/232766331/figure/fig2/AS:667591068631043@1536177522180/GOLD-2011-pharmacologic-management-of-COPD-based-on-combined-assessment-of-airflow.png)
GOLD 2011 pharmacologic management of COPD based on combined assessment... | Download Scientific Diagram
![Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study - ScienceDirect Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0954611118302397-gr4.jpg)
Clinical characteristics and medication patterns in patients with COPD prior to initiation of triple therapy with ICS/LAMA/LABA: A retrospective study - ScienceDirect
![The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. - Abstract - Europe PMC The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7046086/bin/nihms-1562254-f0005.jpg)
The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. - Abstract - Europe PMC
![Management of stable COPD. SABA, short-acting bronchodilator agonist;... | Download Scientific Diagram Management of stable COPD. SABA, short-acting bronchodilator agonist;... | Download Scientific Diagram](https://www.researchgate.net/publication/336127873/figure/fig1/AS:816932626386944@1571783324021/Management-of-stable-COPD-SABA-short-acting-bronchodilator-agonist-LAMA-long-acting.png)